✦ LIBER ✦

303 ENHANCED THERAPY SUCCESS OF RENAL CELL CARCINOMA USING TYROSINE KINASE INHIBITORS COMBINED WITH ROTTLERIN

✍ Scribed by Jöckel, Matthias; Schneider, Elke; Khageh-Hosseini, Sabrina; Roos, Frederik C.; Hampel, Christian; Thüroff, Joachim W.; Brenner, Walburgis

Book ID: 118485083
Publisher: Lippincott Williams and Wilkins
Year: 2012
Tongue: English
Weight: 50 KB
Volume: 187
Category: Article
ISSN: 0022-5347
DOI: 10.1016/j.juro.2012.02.362

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sequential use of mammalian target of ra

Sequential use of mammalian target of rapamycin inhibitors in patients with metastatic renal cell carcinoma following failure of tyrosine kinase inhibitors

✍ Kumano, Masafumi; Miyake, Hideaki; Harada, Ken-ichi; Fujisawa, Masato 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 297 KB

Sequence Therapy in Patients with Metast

Sequence Therapy in Patients with Metastatic Renal Cell Carcinoma: Comparison of Common Targeted Treatment Options Following Failure of Receptor Tyrosine Kinase Inhibitors

✍ Jonas Busch; Christoph Seidel; Carsten Kempkensteffen; Manfred Johannsen; Ingmar 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 518 KB

MP57-03 SEQUENTIAL USE OF MAMMALIAN TARG

MP57-03 SEQUENTIAL USE OF MAMMALIAN TARGET OF RAPAMYCIN INHIBITORS IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA FOLLOWING FAILURE OF TYROSINE KINASE INHIBITORS

✍ Harada, Ken-ichi; Miyake, Hideaki; Fujisawa, Masato 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 143 KB

Tyrosine Kinase Inhibitors Compared with

Tyrosine Kinase Inhibitors Compared with Cytokine Therapy for Metastatic Renal Cell Carcinoma: Overview of Recent Clinical Trials Differentiating Clinical Response and Adverse Effects

✍ Robert Dreicer 📂 Article 📅 2006 🏛 CIG Media Group, LP. 🌐 English ⚖ 151 KB

725 SEQUENTIAL USE OF MTOR -INHIBITORS I

725 SEQUENTIAL USE OF MTOR -INHIBITORS IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC): SAFETY AND EFFICACY FOLLOWING FAILURE OF RECEPTOR TYROSINE KINASE INHIBITOR (TKI) TREATMENT

✍ J. Busch; C. Kempkensteffen; V. Grünwald; L. Weinkauf; S. Hinz; A. Magheli; K. M 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 176 KB

A phase 1b clinical trial of the multi-t

A phase 1b clinical trial of the multi-targeted tyrosine kinase inhibitor lenvatinib (E7080) in combination with everolimus for treatment of metastatic renal cell carcinoma (RCC)

✍ Molina, Ana M.; Hutson, Thomas E.; Larkin, James; Gold, Anne M.; Wood, Karen; Ca 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 395 KB